Literature DB >> 17342637

Reemergence of anaerobic bacteremia.

Britta Lassmann1, Daniel R Gustafson, Christina M Wood, Jon E Rosenblatt.   

Abstract

BACKGROUND: During 1974-1988, the incidence of anaerobic bacteremia at the Mayo Clinic (Rochester, MN) decreased. This trend occurred nationally, prompting calls for discontinuation of routine anaerobic blood cultures. However, recently, the sites of anaerobic infection have been shown not to be as predictable as once thought, and since 1993, the incidence of anaerobic bacteremia has increased significantly in our medical center.
METHODS: Records from the Mayo Clinic Division of Clinical Microbiology were used to tabulate the number of cases of anaerobic bacteremia in patients at the clinic for the 12-year period from 1993 through 2004. Medical records for patients with anaerobic bacteremia were reviewed from the periods of 1993-1994 and 2004 to identify differences between these 2 patient populations with different rates of bacteremia.
RESULTS: The mean incidence of anaerobic bacteremias increased from 53 cases per year during 1993-1996 to 75 cases per year during 1997-2000 to 91 cases per year during 2001-2004 (an overall increase of 74%). The total number of cases of anaerobic bacteremia per 100,000 patient-days increased by 74% (P<.001). The number of anaerobic blood cultures per 1000 cultures performed increased by 30% (P=.002). Organisms from the Bacteroides fragilis group, other species of Bacteroides, and Clostridium species were most commonly isolated.
CONCLUSIONS: Anaerobic bacteremia has reemerged as a significant clinical problem. Although there are probably multiple reasons for this change, the increasing number of patients with complex underlying diseases makes the clinical context for anaerobic infections less predictable than it once was. Anaerobic blood cultures should be routinely performed in medical centers with a patient population similar to ours.

Entities:  

Mesh:

Year:  2007        PMID: 17342637     DOI: 10.1086/512197

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  58 in total

Review 1.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

2.  Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection.

Authors:  Erin B Troy; Vincent J Carey; Dennis L Kasper; Laurie E Comstock
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

3.  Relevance of routine use of the anaerobic blood culture bottle.

Authors:  Patrick Grohs; Jean-Luc Mainardi; Isabelle Podglajen; Xavier Hanras; C Eckert; A Buu-Hoï; E Varon; Laurent Gutmann
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

4.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

5.  Evaluation of the new Vitek 2 ANC card for identification of medically relevant anaerobic bacteria.

Authors:  Francine Mory; Corentine Alauzet; Céline Matuszeswski; Philippe Riegel; Alain Lozniewski
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

Review 6.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  cis-Encoded Small RNAs, a Conserved Mechanism for Repression of Polysaccharide Utilization in Bacteroides.

Authors:  Yanlu Cao; Konrad U Förstner; Jörg Vogel; C Jeffrey Smith
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

8.  Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period.

Authors:  Lukas Fenner; Andreas F Widmer; Clarisse Straub; Reno Frei
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

9.  Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

Authors:  Carmen Betriu; Esther Culebras; María Gómez; Fátima López; Iciar Rodríguez-Avial; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

Review 10.  Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit.

Authors:  Patrick R Murray; Henry Masur
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.